🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

The The National Centre for the 3Rs and OGA community: bringing together stakeholders from across the biosciences to improve the integrity and reproducibility of biomedical research that relies on commercial antibodies. nc3rs.org.uk/news/improving…

Thank you to Rick Kahn, eLife - the journal and all of the co-authors for this excellent overview of initiatives that have and are improving science using antibodies. Keep up the good work everyone! doi.org/10.7554/eLife.…

Excited to share our eLife - the journal review about the ongoing “antibody characterization crisis” and potential solutions. Nice effort by Harvinder Virk, Carl Laflamme, Jim Trimmer, Meghan Rego, IPI’s Rob Meijers and others. Read the paper here: bit.ly/472uUiB

🎉Celebrating a new milestone: Over 100 antibody characterization reports #openly available on our Zenodo community, with several converted to peer-reviewed F1000 publications! ➡️zenodo.org/communities/yc… ➡️f1000research.com/gateways/ychar…

Better antibodies, better science, better treatments. le.ac.uk/research/insti…

Harvinder Virk #EMIRA speaking to the challenges of progressing drug development & research alongside MDT assessment delays... strategies afoot including YCHARUS better antibodies better science better patient outcomes Amanda Tatler Bibek Gooptu ILD-IN

Neuroscientist Carl Laflamme describes YCharOS, an initiative testing commercial antibodies to determine if they work as advertised, and making findings open to improve research efficiency and reproducibility. via nature buff.ly/40AgsNn #OpenScience

Poorly performing antibodies have plagued biomedical sciences for decades. Several fresh initiatives hope to change this go.nature.com/3NYdY42

Thank you Diana Kwon for the great news feature in Nature about the public good YCharOS effort

Thank you to nature and Diana Kwon for featuring YCharOS and our community - and showing the progress we are making! nature.com/articles/d4158…

Fantastic to see this Nature feature article promoting our work with OnlyGoodAntibodies and YCharOS. We aim to promote a change in biomedical research culture and #openscience practices with a specific focus on antibody validation.

Fantastic to see our work with the OnlyGoodAntibodies highlighted in this article. Poor antibodies waste research funding and time, delay scientific progress and drug development, and lead to unnecessary animal use where in vivo experiments or animal-derived products are involved.

We are working with the OGA to raise awareness of the importance of improving reproducibility of research involving antibodies, for better science that is more efficient, reliable and reduces or replaces the use of animals. nc3rs.org.uk/news/improving…

Non-animal derived antibodies and affinity reagents are part of the solution. We are working to accelerate their uptake as alternatives to traditional antibodies that are more reproducible and replace animal use. nc3rs.org.uk/news/recommend….

It’s very encouraging that funders support projects like YCharOS, which does not address hypotheses, but rather does the foundational, but not sexy, work of testing and characterizing reagent antibodies in order to make everyone else’s science more robust and reproducible.

Our new website! onlygoodantibodies.com/news/

FUNDED 💰 PHD 🎓 OPPORTUNITY 🙋‍♀️ . Starts Sept 2025, apply via University of Leicester, funded via BBSRC MIBTP. If you are interested, please contact me! This project will work towards the discovery and validation of immune ageing biomarkers. le.ac.uk/study/research…

✍️🚨Check out this *new #blog* from the #NIHRLeicesterBRC's Harvinder Virk “New protocol will drive a shared roadmap towards more reliable and cost-effective use of #antibodies in biomedical research.” including links to papers published in Nature Protocols this month.